Tilray Brands, Inc.

TSX:TLRY.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$3.23 -1.19%

-$0.08 today

Market cap
$477.35M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $0.49High $21.57

Volume 0.86M

Average 0.64M

TLRY.TO Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Tilray Brands, Inc.TSX: TLRY.TO

Income Tax Expense · Q3 FY2026 · quarter ended Feb 2026

Income tax expense growth accelerates

Q3 FY2026 income tax expense of $1.97M rose 64.1% year over year, ahead of the -418.7% change in trailing-twelve-month income tax expense. Sequentially, it fell 44.3% from the prior quarter.

Context

  • Income tax expense amounted to 14.7% of revenue in FY2025, up 11.4 pp from a year earlier.
  • Income tax expense grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +64.1% holds above the trailing-twelve-month pace of -418.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$1.97M-44.3% QoQ
Last fiscal yearMay 2025
-$121.02M-354.7% YoY
LTMFeb 2026
-$121.91M-418.7% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+64.1%——
1 year-354.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
(121.02M) USD
Year-over-year change
-354.7%

Income Tax Expense vs competitors

How TLRY.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -418.7% is the lowest of 3, against a peer median of +20.0%.
  • Income tax expense amounts to 14.2% of revenue for TLRY.TO, versus a peer median of 0.6%.
TLRY.TO Competitors
Income Tax Expense for TLRY.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACBAurora Cannabis Inc.LTM Mar 2026CA$2.93M CAD-36.6%-49.7%0.9%
SNDLSNDL Inc.LTM Mar 2026-CA$1.5M CAD+76.6%—0.2%
TLRY.TOTilray Brands, Inc.LTM Feb 2026-$121.91M USD-418.7%—14.2%
GLASGlass House Brands Inc—— ———
Peer median (excluding TLRY.TO) —+20.0%-49.7%0.6%

Competitors are the stored peer set for TLRY.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue513.09M628.37M630.88M788.94M821.31M
Cost of Revenue389.9M511.56M480.16M565.59M580.74M
Gross Profit123.18M116.82M146.96M223.35M240.57M
Gross Margin24.0%18.6%23.3%28.3%29.3%
Research & Development830K1.52M686.09K635K284K
Selling, General & Admin155.69M228.66M232.32M250.72M259.48M
Operating Expenses255.35M215.66M1.04B398.1M2.52B
Depreciation & Amortization67.83M154.59M130.15M126.91M133.49M
EBITDA(246.25M)(246.4M)(1.27B)(72.84M)(2.13B)
EBITDA Margin-48.0%-39.2%-201.8%-9.2%-259.0%
Operating Income(68.55M)(98.85M)(185.85M)(174.75M)(2.28B)
Operating Margin-13.4%-15.7%-29.5%-22.1%-277.9%
Interest Income2.93M11.74M33.03M12.83M11.38M
Interest Expense30.9M39.68M13.59M49.26M41.33M
Other Income / Expenses(212.82M)(341.83M)(1.27B)(74.28M)(19.67M)
Income Before Tax(344.99M)(440.67M)(1.46B)(249.02M)(2.3B)
Pre-Tax Margin-67.2%-70.1%-231.3%-31.6%-280.3%
Income Tax Expense(8.97M)(6.54M)(7.18M)(26.62M)(121.02M)
Net Income(367.42M)(440.67M)(1.44B)(244.98M)(2.19B)
Net Margin-71.6%-70.1%-228.7%-31.1%-266.3%
EPS (Basic)(13.63)(9.95)(23.40)(3.30)(24.10)
EPS (Diluted)(13.63)(9.95)(23.40)(3.30)(24.10)
Weighted Avg Shares26.95M48.12M61.8M74.26M90.83M
Weighted Avg Shares (Diluted)26.95M48.12M61.8M74.26M90.83M

Tilray Brands, Inc.

TSX:TLRY.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.